This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Analyst Blog: Archive
How Will These 3 Energy Stocks Perform This Earnings Season?
by Turjya Saha
Here is what to expect from CRC, SDRL and INR stocks ahead of their quarterly earnings reports, which are set to be released on Aug. 10, 2026.
SDRLNegative Net Change CRCNegative Net Change INRPositive Net Change
energy oil-energy
What to Expect From These 2 Utility Stocks This Season?
by Jewel Saha
PPL and Vistra head into Q2 release with support from data-center demand, new rates, clean-energy investment and disciplined cost controls.
PPLNegative Net Change VSTNegative Net Change
earnings utilities
What's in Store for These 3 Networking Stocks This Earnings Season?
by Vaishali Doshi
Cisco, Intrusion and RADCOM face a mixed earnings setup as AI networking demand rises, while cautious IT spending, costs and deployment delays weigh.
CSCOPositive Net Change RDCMPositive Net Change INTZPositive Net Change
tech-stocks
Will These 3 Insurance Stocks Insure a Q2 Earnings Beat?
by Rajshree Sipani
AFL appears best positioned for a Q2 earnings beat as favorable industry trends and a positive Earnings ESP set it apart from AIG and OSG.
AIGPositive Net Change AFLNegative Net Change OSGPositive Net Change
automation earnings fin-tech finance insurance medical smart-health
What to Expect From These 2 MedTech Stocks This Earnings Season?
by Sridatri Sarkar
Globus Medical and Resmed enter the earnings season with growth drivers intact despite tariff, inflation and hospital spending pressures.
RMDPositive Net Change GMEDPositive Net Change
earnings medical
What's in Store for These 4 Healthcare Companies This Earnings Season?
by Indrajit Bandyopadhyay
McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs, funding pressure and pricing challenges.
MCKPositive Net Change CORPositive Net Change PACBPositive Net Change SOLVPositive Net Change
medical medical-devices
Watch These 4 Beverage Stocks as Q2 Earnings Take Center Stage
by Rajani Lohia
Beverage earnings highlight volume-led growth, premiumization and margin discipline as value-conscious consumers and stubborn costs reshape Q2 trends.
TAPPositive Net Change MNSTPositive Net Change KDPPositive Net Change PRMBPositive Net Change
consumer-staples
ALL, MET or RDN: Which Insurer is Best Positioned for a Q2 Beat?
by Kaibalya Pravo Dey
Commercial pricing, investment income and underwriting trends are in focus as Allstate, MetLife and Radian Group prepare to report Q2 earnings.
METPositive Net Change ALLNegative Net Change RDNNegative Net Change
earnings finance insurance
Can These 3 MedTech Stocks Hit Targets This Earnings Season?
by Moumi Mondal
Can Zimmer Biomet, Charles River Laboratories and Bio-Techne meet earnings expectations? See the MedTech trends and company-specific drivers in focus.
CRLPositive Net Change TECHPositive Net Change ZBHPositive Net Change
earnings medical medical-devices
Are These 5 Pharma Stocks Set to Surpass Q2 Earnings Forecasts?
by Sundeep Ganoria
Amgen, Pfizer, Eli Lilly, Merck and Novo Nordisk are set to report Q2 results this week after a strong start for pharma earnings. Which names could beat forecasts?
PFEPositive Net Change NVOPositive Net Change MRKPositive Net Change LLYPositive Net Change AMGNPositive Net Change
biotechs earnings medical pharmaceuticals vaccines